These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14750503)

  • 1. A peptide isolated from alpha B-crystallin is a novel and potent inhibitor of platelet aggregation via dual prevention of PAR-1 and GPIb/V/IX.
    Matsuno H; Ishisaki A; Nakajima K; Kato K; Kozawa O
    J Thromb Haemost; 2003 Dec; 1(12):2636-42. PubMed ID: 14750503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Novel physiological roles of low molecular weight HSPs].
    Matsuno H; Kozawa O
    Nihon Yakurigaku Zasshi; 2003 Jan; 121(1):21-5. PubMed ID: 12617034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis.
    Lei X; Reheman A; Hou Y; Zhou H; Wang Y; Marshall AH; Liang C; Dai X; Li BX; Vanhoorelbeke K; Ni H
    Thromb Haemost; 2014 Feb; 111(2):279-89. PubMed ID: 24172860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
    De Luca M; Facey DA; Favaloro EJ; Hertzberg MS; Whisstock JC; McNally T; Andrews RK; Berndt MC
    Blood; 2000 Jan; 95(1):164-72. PubMed ID: 10607699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycoprotein Ib alpha peptides inhibit thrombin and SFLLRN-induced platelet aggregation.
    McKeown LP; Williams SB; Hansmann KE; Krutzsch H; Gralnick HR
    J Lab Clin Med; 1996 Nov; 128(5):492-5. PubMed ID: 8900292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The possibility of novel antiplatelet peptides: the physiological effects of low molecular weight HSPs on platelets.
    Kanno Y; Matsuno H
    Curr Pharm Des; 2006; 12(7):887-92. PubMed ID: 16515504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib.
    Fujimura Y; Ikeda Y; Miura S; Yoshida E; Shima H; Nishida S; Suzuki M; Titani K; Taniuchi Y; Kawasaki T
    Thromb Haemost; 1995 Aug; 74(2):743-50. PubMed ID: 8585016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human factor XII binding to the glycoprotein Ib-IX-V complex inhibits thrombin-induced platelet aggregation.
    Bradford HN; Pixley RA; Colman RW
    J Biol Chem; 2000 Jul; 275(30):22756-63. PubMed ID: 10801853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant fragment of von Willebrand factor AR545C inhibits platelet binding to thrombin and platelet adhesion to thrombin-treated endothelial cells.
    Dardik R; Varon D; Eskaraev R; Tamarin I; Inbal A
    Br J Haematol; 2000 Jun; 109(3):512-8. PubMed ID: 10886196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of protease-activated receptors 1 and 4 and glycoprotein Ib-IX-V in the G(i)-independent activation of platelet Rap1B by thrombin.
    Lova P; Campus F; Lombardi R; Cattaneo M; Sinigaglia F; Balduini C; Torti M
    J Biol Chem; 2004 Jun; 279(24):25299-306. PubMed ID: 15078882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role for platelet glycoprotein Ib-IX and effects of its inhibition in endotoxemia-induced thrombosis, thrombocytopenia, and mortality.
    Yin H; Stojanovic-Terpo A; Xu W; Corken A; Zakharov A; Qian F; Pavlovic S; Krbanjevic A; Lyubimov AV; Wang ZJ; Ware J; Du X
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2529-37. PubMed ID: 24051142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib.
    Soslau G; Class R; Morgan DA; Foster C; Lord ST; Marchese P; Ruggeri ZM
    J Biol Chem; 2001 Jun; 276(24):21173-83. PubMed ID: 11283012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. von Willebrand factor mediates platelet spreading through glycoprotein Ib and alpha(IIb)beta3 in the presence of botrocetin and ristocetin, respectively.
    McCarty OJ; Calaminus SD; Berndt MC; Machesky LM; Watson SP
    J Thromb Haemost; 2006 Jun; 4(6):1367-78. PubMed ID: 16706984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic effect of platelet glycoprotein Ib-blocking monoclonal antibody Fab fragments in nonhuman primates.
    Cauwenberghs N; Meiring M; Vauterin S; van Wyk V; Lamprecht S; Roodt JP; Novák L; Harsfalvi J; Deckmyn H; Kotzé HF
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1347-53. PubMed ID: 10807753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist.
    Kato Y; Kita Y; Nishio M; Hirasawa Y; Ito K; Yamanaka T; Motoyama Y; Seki J
    Eur J Pharmacol; 1999 Nov; 384(2-3):197-202. PubMed ID: 10611442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic peptide from the V3 loop consensus motif with a potent anti-HIV activity inhibits ristocetin-mediated vWF-GPIb interaction.
    Mohri H; Asakura Y; Fukushima J; Kawamoto S; Okubo T; Okuda K
    Peptides; 1997; 18(9):1289-93. PubMed ID: 9392827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic effect of crotalin, a platelet membrane glycoprotein Ib antagonist from venom of Crotalus atrox.
    Chang MC; Lin HK; Peng HC; Huang TF
    Blood; 1998 Mar; 91(5):1582-9. PubMed ID: 9473223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human kininogens regulate thrombin binding to platelets through the glycoprotein Ib-IX-V complex.
    Bradford HN; Dela Cadena RA; Kunapuli SP; Dong JF; Löpez JA; Colman RW
    Blood; 1997 Aug; 90(4):1508-15. PubMed ID: 9269768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The preparation and characterization of novel peptide antagonists to thrombin and factor VIIa and activation of protease-activated receptor 1.
    Nieman MT; Warnock M; Hasan AA; Mahdi F; Lucchesi BR; Brown NJ; Murphey LJ; Schmaier AH
    J Pharmacol Exp Ther; 2004 Nov; 311(2):492-501. PubMed ID: 15210836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antithrombotic effect of aurin tricarboxylic acid in the guinea pig is not solely due to its interaction with the von Willebrand factor-GPIb axis.
    Azzam K; Cissé-Thiam M; Drouet L
    Thromb Haemost; 1996 Jan; 75(1):203-10. PubMed ID: 8713802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.